Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y7YH
|
|||
| Former ID |
DIB008916
|
|||
| Drug Name |
TK-54
|
|||
| Synonyms |
Modified T cell therapy (GVHD), LTKfarma; Modified T cell therapy (GVHD), Pierre et Marie Curie University; ModifiedT cell therapy (graft versus host disease), LTKfarma
Click to Show/Hide
|
|||
| Indication | Graft-versus-host disease [ICD-11: 4B24; ICD-9: 279.5] | Phase 1/2 | [1] | |
| Company |
Universite Pierre et Marie Curie
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024880) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.